期刊文献+

术前FIB和PLT检测对上尿路尿路上皮癌病人预后评估价值 被引量:1

VALUE OF PREOPERATIVE FIB AND PLT IN ASSESSING THE PROGNOSIS OF PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA
下载PDF
导出
摘要 目的探讨术前纤维蛋白原(FIB)和血小板(PLT)计数评估上尿路尿路上皮癌(UUTUC)病人预后的价值。方法回顾性分析2005年1月—2011年12月于我院行手术治疗的140例非转移性UUTUC病人的临床资料。比较术前不同FIB和PLT水平病人临床病理特征的差异,应用Kaplan-Meier法和Log-rank检验进行生存分析,应用Cox比例风险回归模型进行预后的危险因素分析。结果低FIB(<4.0g/L)组与高FIB(≥4.0g/L)组病人临床病理特征比较,仅病理分期差异有统计学意义(χ2=7.241,P<0.01)。高PLT组各临床病理指标与低PLT组比较差异均无显著性(P>0.05)。低FIB组与高FIB组肿瘤特异性生存率和无复发生存率差异有统计学意义(χ2=8.192、7.162,P<0.05)。病理分期、术前FIB是病人肿瘤特异性生存的独立危险因素(HR=13.097、0.429,P<0.05)。结论术前FIB是UUTUC病人肿瘤特异性生存的独立危险因素,术前FIB≥4.0g/L的病人预后差。术前PLT计数对UUTUC病人预后无明显影响。 Objective To investigate the value of preoperative fibrinogen(FIB)and platelet(PLT)count in assessing the prognosis of patients with upper urinary tract urothelial carcinoma(UUTUC).Methods We retrospectively analyzed the clinical data of 140 patients with non-metastatic UUTUC who underwent surgical treatment in our hospital from January 2005 to December 2011.Clinicopathological features were compared between patients with different preoperative FIB levels and PLTs.Survival analysis was performed using Kaplan-Meier method and log-rank test,and risk factor analysis was performed using the Cox proportional hazards regression model.Results There was only a significant difference in pathological staging between low-FIB group(4.0 g/L)and high-FIB group(≥4.0 g/L)(χ^2=7.241,P〈0.01).However,there was no significant difference in each clinicopathological feature between high-PLT group and low-PLT group(P〈0.05).There were significant differences in cancerspecific survival rate and recurrence-free survival rate between low-FIB group and high-FIB group(χ^2=8.19,7.162;P〈0.05).Pathological staging and preoperative FIB were independent risk factors for cancer-specific survival(HR=13.097 and 0.429,both P〈0.05).Conclusion Preoperative FIB is an independent risk factor for cancer-specific survival in patients with UUTUC.Patients with high preoperative FIB levels(≥4.0 g/L)have poor prognosis.Preoperative PLT has no significant effect on the prognosis of patients with UUTUC.
作者 宋鑫 俞程程 贺平丽 柴东岳 孙立江 SONG Xin;YU Chengcheng;HE Pingli;CHAI Dongyue;SUN Lijiang(Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao 266003, Chin)
出处 《齐鲁医学杂志》 2017年第5期530-533,共4页 Medical Journal of Qilu
关键词 尿道肿瘤 纤维蛋白原 血小板计数 预后 urethral neoplasms fibrinogen platelet count prognosis
  • 相关文献

参考文献1

二级参考文献31

  • 1Hundal R, Shaffer EA. Gallbladder cancer: epidemiology andoutcome. Clin Epidemiol 2014; 6: 99-109 [PMID: 24634588 DOI:10.2147/clep.s37357].
  • 2Wu XS, Shi LB, Li ML, Ding Q, Weng H, Wu WG, Cao Y, BaoRF, Shu YJ, Ding QC, Mu JS, Gu J, Dong P, Liu YB. Evaluationof two inflammation-based prognostic scores in patients withresectable gallbladder carcinoma. Ann Surg Oncol 2014; 21:449-457 [PMID: 24081806 DOI: 10.1245/s10434-013-3292-z].
  • 3Shu YJ, Weng H, Bao RF, Wu XS, Ding Q, Cao Y, Wang XA,Zhang F, Xiang SS, Li HF, Li ML, Mu JS, Wu WG, Liu YB.Clinical and prognostic significance of preoperative plasmahyperfibrinogenemia in gallbladder cancer patients followingsurgical resection: a retrospective and in vitro study. BMC Cancer2014; 14: 566 [PMID: 25096189 DOI: 10.1186/1471-2407-14-566].
  • 4Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z, Liu C, Shen B, WangXA, Wu W, Zhou D, Zhang D, Wang T, Liu B, Qu K, Ding Q,Weng H, Ding Q, Mu J, Shu Y, Bao R, Cao Y, Chen P, Liu T, JiangL, Hu Y, Dong P, Gu J, Lu W, Shi W, Lu J, Gong W, Tang Z, ZhangY, Wang X, Chin YE, Weng X, Zhang H, Tang W, Zheng Y, He L,Wang H, Liu Y, Liu Y. Whole-exome and targeted gene sequencingof gallbladder carcinoma identifies recurrent mutations in the ErbBpathway. Nat Genet 2014; 46: 872-876 [PMID: 24997986 DOI:10.1038/ng.3030].
  • 5Choi SB, Han HJ, Kim CY, Kim WB, Song TJ, Suh SO, KimYC, Choi SY. Fourteen year surgical experience of gallbladdercancer: validity of curative resection affecting survival. Hepatogastroenterology2012; 59: 36-41 [PMID: 22251521 DOI:10.5754/hge10297].
  • 6Wang RT, Xu XS, Liu J, Liu C. Gallbladder carcinoma: analysisof prognostic factors in 132 cases. Asian Pac J Cancer Prev 2012;13: 2511-2514 [PMID: 22938413].
  • 7Feng JF, Huang Y, Lu WS, Chen QX. Preoperative platelet countin esophageal squamous cell carcinoma: is it a prognostic factor-Langenbecks Arch Surg 2013; 398: 1115-1122 [PMID: 24013712DOI: 10.1007/s00423-013-1111-4].
  • 8Wan S, Lai Y, Myers RE, Li B, Hyslop T, London J, Chatterjee D,Palazzo JP, Burkart AL, Zhang K, Xing J, Yang H. Preoperativeplatelet count associates with survival and distant metastasisin surgically resected colorectal cancer patients. J GastrointestCancer 2013; 44: 293-304 [PMID: 23549858 DOI: 10.1007/s12029-013-9491-9].
  • 9Brown KM, Domin C, Aranha GV, Yong S, Shoup M. Increasedpreoperative platelet count is associated with decreased survival afterresection for adenocarcinoma of the pancreas. Am J Surg 2005; 189:278-282 [PMID: 15792750 DOI: 10.1016/j.amjsurg.2004.11.014].
  • 10Roayaie S, Obeidat K, Sposito C, Mariani L, Bhoori S,Pellegrinelli A, Labow D, Llovet JM, Schwartz M, Mazzaferro V.Resection of hepatocellular cancer .2 cm: results from two Westerncenters. Hepatology 2013; 57: 1426-1435 [PMID: 22576353 DOI:10.1002/hep.25832].

共引文献7

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部